Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 2/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23947418 | 0.96 | PRKDC (0.35) | PRKDCALOX5KDM4EATML3MBTL1 | |
| SCHEMBL22257941 | 0.94 | PRKDC (0.35) | PRKDCALOX5 | |
| SCHEMBL22257875 | 0.94 | PRKDC (0.35) | PRKDCALOX5 | |
| SCHEMBL21795217 | 0.94 | ALOX5 (0.35) | PRKDCALOX5KDM4EATML3MBTL1 | |
| SCHEMBL23948020 | 0.93 | PRKDC (0.33) | PRKDCALOX5 | |
| SCHEMBL24216018 | 0.92 | PRKDC (0.39) | PRKDCALOX5KDM4EATML3MBTL1 | |
| SCHEMBL23947924 | 0.92 | PRKDC (0.34) | PRKDCALOX5KDM4EATML3MBTL1 | |
| SCHEMBL25927858 | 0.92 | PRKDC (0.35) | PRKDCALOX5 | |
| SCHEMBL23947119 | 0.92 | PRKDC (0.35) | PRKDCALOX5KDM4EATML3MBTL1 | |
| SCHEMBL25927860 | 0.92 | PRKDC (0.36) | PRKDCALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873297-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-20210323948-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323948-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CCNL2, UBE2L3, OPRL1 | PRKDC 4727/4885ALOX5 2287/4885KDM4E 3842/4885 |
| US-11873297-B2 | Compound and organic light emitting device comprising the same | CCNL2, UBE2L3, ARL1 | PRKDC 4742/4885ALOX5 2234/4885KDM4E 3695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.